SciPro is partnered with a consulting firm seeking a Principal, Market Access to lead and expand its market access practice, partnering with pharmaceutical and biotech clients from Phase II through launch to shape payer strategy, readiness planning, and value communication. This leader will refine service offerings, oversee client deliverables, and drive business development by leveraging strong client relationships and deep knowledge of the payer and pricing landscape. The role requires the ability to synthesize insights into clear, actionable recommendations while managing and mentoring teams to execute high-quality deliverables that support launch and in-line product success. Travel up to 25% may be required. Responsibilities: Refine and expand market access service offerings. Lead client engagements on payer strategy, pricing, and access insights. Synthesize findings into clear, actionable recommendations. Manage and mentor teams to ensure high-quality deliverables. Drive business development with existing and new clients. Monitor market trends to inform client strategy and competitive positioning. Requirements: Bachelor’s in life sciences (MBA preferred). 10+ years in pharmaceutical market access, including 5+ in consulting. Proven track record in delivering results and driving business growth. Deep understanding of payer, pricing, and access strategy. Strong communication, leadership, and client management skills. Willingness to travel up to 25%.

Director / Sr. Director, Health Economics & Outcomes Research (HEOR) Biopharma / Rare Disease FocusAbout the Role An innovative biopharma organization focused on rare diseases is seeking a Director or Sr. Director of Health Economics & Outcomes Research to support early and late-stage programs across a diverse pipeline. This position plays a key role in shaping evidence strategies to demonstrate clinical and economic value, enable patient access, and inform product development.Key Responsibilities Lead the design and execution of HEOR strategies for products in development. Generate evidence through literature reviews, real-world data analysis, and health economic modeling. Develop cost-effectiveness and budget impact models to support value demonstration. Support global market access and HTA submissions, including preparation of dossiers and responses to queries. Collaborate cross-functionally with clinical, regulatory, commercial, and market access teams to align HEOR objectives with business needs. Communicate insights through reports, publications, and presentations to internal and external stakeholders. Qualifications Master’s degree or higher in health economics, epidemiology, or related field. 8+ years of relevant HEOR experience within the pharmaceutical or biotech industry. Background in rare diseases and early-stage development preferred. Experience supporting global launches and HTA submissions. Proven ability to synthesize evidence and develop health economic models. Strong understanding of payer and reimbursement requirements. Willingness to travel domestically and internationally as needed.

Director, Real World Evidence United States – Remote We're currently partnered with a biotech company seeking a Director of Real World Evidence to lead RWE strategy across development and commercialization. This role will shape how data is used to support clinical development, regulatory submissions, market access, and ongoing product adoption. Key Responsibilities: Develop and drive RWE strategy for pipeline and marketed products. Design and oversee studies using diverse data sources (claims, EMR, registries). Generate evidence to support regulatory, payer, and HTA needs. Partner cross-functionally and with external stakeholders to ensure evidence informs access and clinical practice. Lead dissemination of findings through publications and conferences. Qualifications: Advanced degree (PhD, MD, PharmD, or Master’s) with 10+ years of relevant experience. Background in biotech or pharma; rare disease experience preferred. Strong expertise in observational research, study design, and global RWE/HTA requirements. Proven communication, leadership, and project management skills.

This innovative, late-phase biotech is seeking a Vice President, Head of Quality to define and lead all quality functions across the organization. This role will ensure compliance and operational excellence from early development through commercialization, supporting the company’s mission to bring advanced biologic therapies to patients globally. In this role, you will report to the C-Suite and play a pivotal role in quality strategy, regulatory readiness, and team leadership, overseeing all quality functions. Qualifications: Advanced scientific degree (Master’s accepted, PhD preferred) in a relevant life sciences discipline.Extensive experience (15+ years) in Quality Assurance within pharmaceutical or biotech organizations, with at least 8 years in executive leadership roles.Expertise in biologics development, including large molecule therapeutics and sterile manufacturing.Proven record of guiding products through late-stage development and market launch.In-depth knowledge of global regulatory standards, including FDA, EMA, and ICH, across GMP, GLP, GCP, and GDP.Experience managing and evaluating the performance of external partners such as CDMOs, CROs, and suppliers.Strong history of designing, implementing, and scaling Quality Systems to support organizational growth.  Key Responsibilities: Develop and implement a comprehensive quality strategy aligned with company goals.Build, mentor, and lead a high-performing Quality team, fostering accountability and professional growth.Create and maintain flexible Quality processes suitable for all stages of product development, from pre-IND through commercialization.Oversee global third-party partners to ensure adherence to quality standards and contractual obligations.Lead preparation for regulatory inspections and submissions, proactively addressing issues and mitigating risk.Collaborate with cross-functional teams to integrate quality considerations into operational and strategic decisions.Manage financial and resource planning for the Quality function, optimizing efficiency and impact.  This is a fully remote role with approximately 20% travel, including international travel and occasional evening meetings to coordinate with global teams. There is a strong preference towards candidates on Pacific time.

I am working with a healthcare AI company seeking an experienced Vice President of Sales for Providers to lead new business generation and revenue growth across provider organizations, including hospitals, Accountable Care Organizations (ACOs), and physician/medical practices. This role focuses on selling a predictive, AI-driven healthcare platform that improves patient outcomes, reduces costs, and identifies patients at risk before diagnosis. This is a highly profitable company, having secured funding from sophris capital. Key Responsibilities: Drive new business by identifying, engaging, and closing partnerships with hospitals, ACOs, and physician practicesPromote the AI platform through solution-based, consultative selling tailored to provider needsDevelop and manage a robust pipeline, achieving quarterly and annual revenue targetsBuild relationships with decision-makers, including physicians (Nephrology, Cardiology, GP), practice managers, and C-suite executivesCollaborate with internal teams, including product development and marketing, to deliver customized proposalsProvide market and competitor insights to guide commercial strategy and positioning  Qualifications: Proven track record selling to hospitals, providers, ACOs, or physician practices, ideally with experience in AI, SaaS, medical devices, or healthcare data solutions8–15+ years of business development or sales experience in healthcare provider marketsDemonstrated ability to close large, complex deals ($1M+ ARR) and navigate long sales cyclesStrong understanding of healthcare economics, value-based care, and provider decision-makingExceptional communication skills with experience engaging C-level executives and clinical stakeholders